10:19 AM
Aug 02, 2017
 |  BC Extra  |  Preclinical News

U.S. researchers buck embryo editing guidelines

In direct contravention of the position against germline gene editing taken by NIH, a team led by scientists from Oregon Health & Science University published a study in Nature on Wednesday detailing CRISPR-Cas9-mediated gene correction of human embryos.

The group included researchers from the Salk Institute of Biological Sciences, Korea's Institute for Basic Science, Seoul National University and BGI Group in China. Funding for the study included OHSU institutional funds, contributions from several charitable foundations and funding from the Shenzhen Municipal Government of China.

The study is the first in the U.S. to document research on gene editing in human embryos, which differs from editing somatic cells because the changes are carried through to future generations. Three other Chinese groups have reported gene editing of human embryos since April 2015.


Read the full 664 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >